FDA Approves MEXILETINE HYDROCHLORIDE — Macleods Pharmaceuticals Limited

# FDA Approves Generic Mexiletine Hydrochloride from Macleods Pharmaceuticals Macleods Pharmaceuticals Limited has received FDA approval for its generic mexiletine hydrochloride oral formulation (ANDA219987), expanding treatment options for patients with ventricular arrhythmias while intensifying competition in the antiarrhythmic drug market. The approval is expected to increase price competition and improve medication accessibility, potentially benefiting both patients and healthcare payers seeking cost-effective alternatives to branded versions.